- Home
- SKYE vs BVFL Comparison
SKYE vs BVFL Comparison
Compare SKYE & BVFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- BVFL
- Stock Information
- Founded
- SKYE 2012
- BVFL 1873
- Country
- SKYE United States
- BVFL United States
- Employees
- SKYE N/A
- BVFL N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- BVFL Savings Institutions
- Sector
- SKYE Health Care
- BVFL Finance
- Exchange
- SKYE Nasdaq
- BVFL Nasdaq
- Market Cap
- SKYE 108.5M
- BVFL 150.2M
- IPO Year
- SKYE N/A
- BVFL N/A
- Fundamental
- Price
- SKYE $3.91
- BVFL $16.56
- Analyst Decision
- SKYE Buy
- BVFL
- Analyst Count
- SKYE 7
- BVFL 0
- Target Price
- SKYE $15.50
- BVFL N/A
- AVG Volume (30 Days)
- SKYE 314.0K
- BVFL 39.2K
- Earning Date
- SKYE 11-06-2025
- BVFL 10-20-2025
- Dividend Yield
- SKYE N/A
- BVFL N/A
- EPS Growth
- SKYE N/A
- BVFL 27.09
- EPS
- SKYE N/A
- BVFL 1.07
- Revenue
- SKYE N/A
- BVFL $38,333,000.00
- Revenue This Year
- SKYE N/A
- BVFL N/A
- Revenue Next Year
- SKYE N/A
- BVFL N/A
- P/E Ratio
- SKYE N/A
- BVFL $15.52
- Revenue Growth
- SKYE N/A
- BVFL 2.48
- 52 Week Low
- SKYE $1.14
- BVFL $13.53
- 52 Week High
- SKYE $6.01
- BVFL $18.19
- Technical
- Relative Strength Index (RSI)
- SKYE 54.00
- BVFL 53.14
- Support Level
- SKYE $3.71
- BVFL $16.44
- Resistance Level
- SKYE $4.55
- BVFL $16.74
- Average True Range (ATR)
- SKYE 0.31
- BVFL 0.20
- MACD
- SKYE 0.02
- BVFL -0.05
- Stochastic Oscillator
- SKYE 49.61
- BVFL 30.61
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.